Abstract:Hintergrund Die Indikation zur elektiven Neck Dissection (END) bei Patienten mit T1/2-Plattenepithelkarzinomen des Hypopharynx (HPSCC) und Oropharynx (OPSCC) wird nicht einheitlich gestellt. In der vorliegenden Studie erfolgte daher eine detaillierte Analyse des Metastasierungsverhaltens von HPSCC und OPSCC. Material und Methoden Es erfolgte eine multizentrische retrospektive Analyse des nodalen Metastasierungsverhaltens und der onkologischen Parameter von 262 chirurgisch therapierten HPSCC- und OPSCC-Patienten. Zudem erfolgte eine systematische Literaturrecherche. Ergebnisse Bei HPSCC-Patienten lag in 62,1% der Fälle eine Diskrepanz zwischen klinischem und pathologischem N-Status vor, bei OPSCC in 52,4% (p16-) bzw. 43,6% (p16+). Die okkulte Metastasierungsrate in den Primärtumorstadien T1/2 lag dabei bei 38,9% für HPSCC und bei 17,8% (p16-) und 11,1% (p16+) für OPSCC. Bei HPSCC traten in den Stadien cT1/2cN0 in 22,2% der Fälle kontralaterale Metastasen auf; die Rate bei OPSCC lag bei lediglich 9,1% (p16-) bzw. 0% (p16+). Patienten mit p16-positiven OPSCC wiesen ein besseres rezidivfreies und Gesamtüberleben auf als p16-negative OPSCC- und HPSCC-Patienten. Ein direkter Zusammenhang zwischen Patientenüberleben und Ausmaß der chirurgischen Therapie des Halses ließ sich nicht nachweisen. Schlussfolgerung Patienten mit HPSCC weisen ab Stadium cT1/2cN0 ein hohes Risiko für okkulte Halslymphknotenmetastasen auf, welches die Durchführung einer beidseitigen END rechtfertigt. Bei Patienten mit T1/2cN0-OPSCC manifestieren sich ipsilateral in >20% der Fälle okkulte Metastasen; das Risiko für eine kontralaterale okkulte Metastasierung liegt jedoch bei <10%, sodass bei streng lateralisierten Tumoren ein Verzicht auf die kontralaterale Neck Dissection erwogen werden kann. Background Due to heterogeneous data, the indication for elective neck dissection (END) in patients with squamous cell carcinoma of the hypopharynx and oropharynx (HPSCC and OPSCC) in stages T1/2N0 is somewhat unclear. Therefore, in this multicenter study, we performed detailed analysis of the metastatic behavior of HPSCC and OPSCC. Material and Methods The nodal metastatic patterns of 262 HPSCC and OPSCC patients who had undergone surgery was retrospectively investigated. In addition, recurrence-free and overall survival were recorded. Furthermore, a systematic literature review on the topic was completed. Results In patients with HPSCC, a discrepancy between clinical and pathologic N status was recorded in 62.1% of patients vs. 52.4% for p16- OPSCC, and 43.6% for p16+ OPSCC. The occult metastasis rate in cT1/2cN0 primary tumors was 38.9% for HPSCC vs. 17.8% (p16- OPSCC) and 11.1% (p16+ OPSCC). Contralateral metastases occurred in 22.2% of cases for HPSCC at stages cT1/2cN0, compared to only 9.1% for p16- OPSCC, and 0% for p16+ OPSCC patients. Patients with p16+ OPSCC had better recurrence-free and overall survival than p16- OPSCC and HPSCC patients. A direct association between patient survival and the extent of neck surgical therapy could not be demonstrated in our patients. Conclusion Patients with HPSCC are at risk for bilateral neck metastases from stage cT1/2cN0, justifying bilateral END. Patients with T1/2 OPSCC present with occult metastases ipsilaterally in >20% of cases; however, the risk for contralateral occult metastasis is <10%. Hence, in strictly lateralized cT1/2CN0 tumors, omission of contralateral END may be considered. Received: 13 November 2023 Accepted after revision: 27 February 2024 Article published online: 03 June 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

When should patients with T1N0 oral squamous cell carcinoma be considered for elective neck dissection?

Elective Neck Dissection in T1N0M0 Oral Squamous Cell Carcinoma: When Is It Necessary?

Can We Identify The Patients With Clinically T1-2n0 Oral Tongue Squamous Cell Carcinoma Benefiting From Neck Dissection?

Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study

Neck Management of Pathological N1 Oral Squamous Cell Carcinoma: a Retrospective Study.

Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?

Neck Dissection of Level Ib for the Treatment of Cn0 HPV-negative Oropharyngeal Squamous Cell Carcinoma: Should It Be Safely Omitted?

Elective neck dissection in clinical stage I squamous cell carcinoma of the tongue: Does it improve regional control or survival time?

Elective neck dissection versus observation in the management of early tongue carcinoma with clinically node-negative neck: a retrospective study of 229 cases.

Sentinel Node Biopsy or Neck Dissection for Early-Stage Oral Cancer For Long Term Follow-Up: Matched-Pair Analysis for pN0 Necks

Neck Nodal Recurrence and Survival of Clinical T1-2 N0 Oral Squamous Cell Carcinoma in Comparison of Elective Neck Dissection Versus Observation: A Meta-Analysis.

[Outcome of Neck Dissection for 154 Cn0/cn1 Patients with Squamous Cell Carcinoma of Hypopharynx and Prognostic Analysis].

Assessment of level IIB lymph nodes in oral cancer - Should we spare or care?

Preservation of level IIb lymph nodes during supraomohyoid neck dissection for clinically node-negative oral squamous cell carcinoma

Nodale Metastasierung und Stellenwert der Neck Dissection bei T1/2-Oro- und Hypopharynxkarzinomen

Comparison of Survival of Patients With T-1(-2) cN(0) Oropharyngeal Cancer Treated With or Without Elective Neck Dissection

[Value of Elective Neck Dissection in Patients with Clinically Stage I Squamous Cell Carcinoma of the Tongue].

Selective Versus Comprehensive Neck Dissection in the Treatment of Patients with a Pathologically Node-Positive Neck with or Without Microscopic Extracapsular Spread in Oral Squamous Cell Carcinoma.

Primary Cn0 Lip Squamous Cell Carcinoma and Elective Neck Dissection: Systematic Review and Meta-Analysis

Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers

Efficacy of selective neck dissection: a review of 123 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of head and neck]